Developer docs
API playgroundTry for free, no card

Search company profiles

Fassisi GmbH

Full company profile

uuid004eok2

Namestring
Fassisi GmbH
Legal namestring
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH
Websiteurl
fassisi.de
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Fassisi GmbH, founded in 2010 and headquartered in the Göttinger Biotechnologiepark (Marie-Curie-Strasse 8, 37079 Göttingen, Germany), is a specialized German manufacturer and developer of point-of-care lateral flow immunoassay (rapid test) systems for veterinary diagnostics. The company produces a portfolio of more than 50 individual rapid test kits covering companion animals (dogs and cats — including Parvo, Corona, FIV, FeLV, Giardia, Leishmania, Lyme, distemper, and vaccination titer tests), large animals (cattle, calves, pigs, lambs, horses, foals — including BoDia variants, BoviPreg for bovine pregnancy, Bovine IgG for passive immunity, PiDia, TetaCheck), and environmental/other applications (BoTick for Borrelia detection in ticks, AllerBovine for bovine allergen detection). The technology platform is built on three proprietary differentiators: the Fassisi-tag (enhanced test performance tag used in products such as FeLFIV), Blue Latex Detection Technology (used in Giardia tests for clearer visual reading), and a Multiplex platform enabling simultaneous detection of multiple pathogens in a single test.

The company operates under audited international quality standards including ISO 9001:2015, GMP certification, and holds manufacturer permits under both §13 AMG (Arzneimittelgesetz) and TierSG (Tierseuchengesetz), a combination that is rare among veterinary rapid test providers. Manufacturing takes place at the Göttingen facility, which was expanded in December 2020 with relocation to larger premises within the Science Park III biotechnology cluster.

Fassisi's revenue model is built on two streams: (1) one-time sales of branded rapid diagnostic test kits through veterinary wholesalers and distribution partners (Vertriebspartner) across Germany, Austria, and Switzerland, supplemented by direct sales via the Fassisi online shop with free domestic shipping above €40; and (2) a smaller professional services stream offering contract development and manufacturing (Auftragsentwicklung) for animal health companies and research institutions requiring custom test development leveraging Fassisi's platform technologies. The company maintains a wholly-owned Austrian subsidiary, Fassisi AT GmbH (established 2017), which distributes specific product lines (T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, CantiCheck Plus) into Austria. GTM is multi-channel: B2B sales-led targeting veterinarians in small and large animal practice, channel partner distribution, and event-driven demand generation with active participation in major veterinary congresses (Leipziger Tierärztekongress, DeutscheVET, bpt-Kongress). The company is privately held with no institutional investor or public market involvement disclosed.

Short descriptiontext

Fassisi GmbH is a Göttingen, Germany-based manufacturer of point-of-care lateral flow rapid diagnostic tests for veterinary use, serving veterinarians and livestock farmers across the DACH region with a portfolio of more than 50 consumable test kits for companion animals, livestock, and equine applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGöttingen, Germany
HQ citystring
Göttingen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary diagnostic tests, rapid immunoassay tests, lateral flow assays, animal health diagnostics, point-of-care testing
Industry5 codes
PRIMARYHLAHAOAL
Veterinary POCT & Rapid Diagnostics (Animal health rapid tests)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMADAD
Veterinary Parasitology Testing
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYAFACADAF
Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation)
SECONDARYHLAMAEAG
Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code2 codes
  • Veterinary Services54194
  • Support Activities for Animal Production1152
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Veterinary Rapid Test Products
TypeOne Time License
Description

One-time sale of rapid diagnostic test kits for veterinary use. Products are sold to veterinarians (Tierärzte) and livestock farmers through veterinary wholesalers, distribution partners, and directly via the Fassisi online shop. The product range covers point-of-care tests for small animals (cats, dogs) and large animals (cattle, calves, pigs, lambs, horses, foals).

fassisi.de
2Contract Development Services
TypeProfessional Services
Description

Custom test development and manufacturing services (Auftragsentwicklung) for customer-specific parameters. Fassisi offers full in-house development and production, leveraging their platform technologies and experience with various species and sample materials. This represents a professional services / project-based revenue stream.

fassisi.de
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Products available via online shop and distribution partners
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products are sold as unit-priced rapid test kits. No tiered pricing structure is publicly disclosed. Shipping is free for orders over €40 in Germany.

fassisi.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Fassisi-tag
Description

Proprietary technology used in Fassisi rapid tests for enhanced test performance and accuracy.

fassisi.de
Core offering1 text field

Fassisi GmbH develops, manufactures, and distributes veterinary in-vitro rapid diagnostic test kits (lateral flow immunoassays) for point-of-care use by veterinarians and livestock producers. The portfolio spans companion-animal pathogen tests (e.g., Parvo, Corona, Giardia, FeLV/FIV, Leishmania, Ehrlichia), canine vector-borne disease panels, and livestock tests for reproductive status, metabolic disorders, passive transfer, and allergen exposure (e.g., BoviPreg, PiDia, Bovine IgG, TetaCheck, AllerBovine). The company also offers contract development and OEM manufacturing services for external animal-health clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • CantiCheck Plus achieved 98.11% sensitivity and 99.99% specificity for CPV antibodies in an independent study (Viruses 2021), outperforming three other commercially available point-of-care tests.
+1 more record
Product overview1 text field

Fassisi GmbH is a German manufacturer and developer of veterinary diagnostic rapid test systems based in Göttingen, Germany. The product portfolio consists of rapid test systems organized into three main categories: products for large animals (cattle, calves, pigs, lambs, horses, and foals), products for small animals (dogs and cats), and environmental/other products. The core technology platform includes the Fassisi Multiplex system enabling multiplex detection. For large animals, key products include BoDia (and its variants: MPX, Advance MPX, Plus, +Gia) for diarrhea pathogens, BoviPreg for bovine pregnancy detection, Bovine IgG for passive immunity assessment, PiDia/PiDia Light for young animal pathogens, and TetaCheck for equine tetanus antibody titers. For small animals, the portfolio includes pathogen-specific tests (Parvo, Corona, FIV, FeLV, GiarDia, LymeBo, EhrCanis, LeishMa, CanDis, CanDiro), combination tests (ParCo, Triple, FeLFIV), and advanced multiplex products (CanVecto 3, CanVecto 4, CantiCheck Plus). The BoTick detects Borrelia in ticks, and AllerBovine detects bovine allergens in dust. The company also offers contract development services for custom diagnostics.

Product and service34 records
1Fassisi Multiplex test platform
CategoryVeterinary Diagnostics — Companion Animal
Description

Proprietary platform combining multiple veterinary pathogen detections in a single lateral flow test, used as the technological basis for the BoDia, Giardia+CPE, and Triple family products.

2BoDia (canine Giardia + blood-detection add-on)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic test for detection of Giardia antigen in dogs, with MPX/Advance MPX/Plus variants adding additional combined antigen detection for the same sample.

3ParCo (Parvovirus + Coronavirus double test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic test that simultaneously detects canine Parvovirus and Coronavirus antigens in fecal samples for differential diagnosis of acute diarrhea in dogs.

4Parvo (canine Parvovirus single test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for canine Parvovirus in fecal samples, used for confirming parvoviral enteritis in dogs.

5Corona (canine Coronavirus single test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for canine Coronavirus in fecal samples.

6GiarDia (canine Giardia single test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for Giardia in canine fecal samples, with a later latex-enhanced version (GiarDia Latex) launched in March 2013.

7Giardia+CPE / Giardia+CPE MPX
CategoryVeterinary Diagnostics — Companion Animal
Description

Multiplex rapid test for combined detection of Giardia and Clostridium perfringens enterotoxin (CPE) in canine fecal samples.

8CryGiDia / CryGiDia MPX
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid antigen test detecting Cryptosporidium and Giardia simultaneously in canine fecal samples.

9Triple / Triple MPX
CategoryVeterinary Diagnostics — Companion Animal
Description

Multiplex rapid test combining detection of three companion-animal pathogens (e.g., Parvo/Corona/Giardia) in a single test cassette.

10ThyroControl Cat / T4
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic semi-quantitative test for total thyroxine (T4) in cats, used for screening and monitoring hyperthyroidism.

11FeLV (Feline Leukemia Virus test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for Feline Leukemia Virus (FeLV p27 antigen) in cat blood samples.

12FIV (Feline Immunodeficiency Virus test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antibody test for Feline Immunodeficiency Virus (FIV) in cat blood samples.

13FeLFIV (combined FeLV + FIV test with Fassisi-tag)
CategoryVeterinary Diagnostics — Companion Animal
Description

Combined rapid test detecting both FeLV antigen and FIV antibody in cat blood samples using Fassisi-tag blue-latex detection technology.

14Feline Triple (Feline ParvoCheck + FeLV + FIV)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic test combining feline panleukopenia (parvovirus) antigen detection with FeLV and FIV screening in cats.

15Feline ParvoCheck
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for feline panleukopenia (feline parvovirus) in fecal samples.

16CanDis (canine Distemper test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for canine Distemper virus (CDV) in ocular or nasal secretions.

17CanDiro (canine Dirofilaria test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antigen test for Dirofilaria immitis (canine heartworm) in dog blood samples.

18LeishMa (canine Leishmaniasis test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic test for Leishmania infantum antibodies/antigens in dog blood samples.

19LymeBo (Lyme Borreliosis test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antibody test for Borrelia burgdorferi (Lyme disease) in dog blood samples.

20EhrCanis (Ehrlichia canis test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antibody test for Ehrlichia canis in dog blood samples.

21EhrLeish (Ehrlichia + Leishmania test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antibody test for combined detection of Ehrlichia and Leishmania exposure in dogs.

22CanVecto Trio
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic antibody panel for combined detection of canine vector-borne pathogens (e.g., Ehrlichia/Anaplasma/Borrelia/Leishmania group) in dog blood samples.

23CanVecto 3
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic three-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.

24CanVecto 4
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic four-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.

25CantiCheck Plus / CantiCheck MPX
CategoryVeterinary Diagnostics — Companion Animal
Description

Multiplex rapid test combining multiple antigen/antibody detections relevant to canine infectious disease screening in a single cassette.

26BoviPreg (bovine pregnancy test)
CategoryVeterinary Diagnostics — Livestock
Description

Rapid on-farm pregnancy test for cattle, detecting pregnancy-associated glycoproteins in serum or plasma.

27Bovine IgG
CategoryVeterinary Diagnostics — Livestock
Description

Rapid test for measurement of bovine IgG in serum or plasma to assess failure of passive transfer in neonatal calves.

28PiDia
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid in-clinic test for fructosamine (glycated protein) in dog and cat serum, used for monitoring long-term glycemic control in diabetic patients.

29PiDia Light
CategoryVeterinary Diagnostics — Companion Animal
Description

Streamlined version of the PiDia fructosamine test for diabetic monitoring in dogs and cats, with reduced workflow for routine practice use.

30TetaCheck (bovine ketone / metabolic test)
CategoryVeterinary Diagnostics — Livestock
Description

Rapid on-farm test for detection of ketone bodies (β-hydroxybutyrate) in bovine milk or blood, used for subclinical ketosis screening in dairy cows.

31Equine IgG
CategoryVeterinary Diagnostics — Equine
Description

Rapid test for measurement of equine IgG in foal serum to assess failure of passive transfer in neonatal foals.

32AllerBovine (bovine allergen exposure test)
CategoryVeterinary Diagnostics — Livestock
Description

Rapid test for detection of allergen-specific IgE antibodies in cattle, used to assess allergen exposure relevant to bovine allergic disease.

33BoTick (Babesia / Babesia spielmanii tick test)
CategoryVeterinary Diagnostics — Companion Animal
Description

Rapid test for detection of Babesia antibodies (including B. spielmanii) in dog blood samples; revised version released July 2013.

34Contract Development Services
CategoryVeterinary Diagnostics — Contract Development / OEM
Description

Service offering under which Fassisi develops and OEM-manufactures custom lateral flow immunoassay veterinary diagnostic tests for external animal-health companies, leveraging the Fassisi-tag platform and GMP/§13 AMG-certified facility.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthersAnnounced on2017-04-07
Description

Fassisi AT GmbH is a subsidiary of Fassisi GmbH based in Austria. It distributes specific Fassisi products in the Austrian market and serves as the Austrian sales and distribution entity. Products distributed include Fassisi T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, and CantiCheck Plus.

2Veterinary Distributors / Wholesalers (Vertriebspartner)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Fassisi sells all products through veterinary distribution partners (Vertriebspartner). These partners distribute Fassisi rapid tests across Germany, Austria, Switzerland, and other German-speaking markets. Distribution partners are the primary route to market for reaching veterinarians and livestock farmers.

fassisi.de
3Scientific Partner Network
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Fassisi maintains a network of scientific partners for handling complex diagnostic questions in custom development projects. This network supports the company's Auftragsentwicklung (contract development) services, enabling development of tests for complex parameters and applications.

fassisi.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global animal health company with a diagnostics portfolio including rapid tests for companion animals and livestock. Virbac's broader pharmaceutical and vaccine offering makes it a broad incumbent that overlaps with Fassisi's on-farm and clinic-based rapid testing.

2Alvedia
TypeEmerging player
Description

French veterinary diagnostics company specializing in rapid blood typing tests for companion animals. Comparable to Fassisi as a focused European veterinary rapid test manufacturer, though Alvedia operates in a narrower niche (blood typing) than Fassisi's broader infectious disease portfolio.

TypeBroad incumbent
Description

Now part of Mars Petcare, Heska sells point-of-care veterinary diagnostics including in-clinic analyzers and rapid test kits for companion animals. The company competes most directly with Fassisi's small animal lateral flow portfolio while also operating broader diagnostic platforms.

TypeBroad incumbent
Description

Global leader in veterinary diagnostics with reference lab services and in-clinic analyzers (Catalyst Dx, ProCyte Dx, SNAP rapid tests). Comparable because SNAP rapid tests directly compete with Fassisi's lateral flow portfolio in companion animal practice, though IDEXX operates at much greater scale and across a broader diagnostics portfolio.

TypeDirect peer
Description

Austrian manufacturer of point-of-care veterinary diagnostic tests and analyzers with a focus on small animal and livestock practice. Closely comparable to Fassisi on technology (lateral flow POC), geographic focus (DACH/Austria), and customer base (veterinary practices and laboratories).

TypeDirect peer
Description

Germany-based developer and manufacturer of veterinary diagnostics, including rapid tests and PCR kits for companion animals and livestock. Highly comparable to Fassisi as a German-headquartered veterinary diagnostics manufacturer serving similar European markets with overlapping product categories.

TypeDirect peer
Description

French veterinary diagnostics manufacturer specializing in ELISA kits and rapid tests for livestock and companion animals. Comparable to Fassisi as a focused veterinary diagnostics manufacturer with B2B distribution to veterinary practices and labs, though IDvet is larger and more export-oriented.

TypeBroad incumbent
Description

Largest global animal health company offering diagnostics, vaccines, and pharmaceuticals. Zoetis's Vetscan rapid test suite and reference lab services overlap with Fassisi's companion animal and livestock offerings, though Zoetis competes across a much broader portfolio and at significantly greater scale.

TypeDirect peer
Description

German-based veterinary diagnostics company offering in-clinic analyzers and rapid tests for companion animals and livestock. Direct peer to Fassisi given similar German-speaking market focus, B2B distribution model, and rapid test product portfolio.

TypeDirect peer
Description

Austrian veterinary diagnostics company selling the FASTest brand of rapid in-clinic tests for companion animals and livestock. Direct peer to Fassisi given overlapping product portfolio (lateral flow POC), regional focus (DACH), and veterinary customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fassisi GmbH

Veterinary Diagnosticsfassisi.de

Fassisi GmbH is a Göttingen, Germany-based manufacturer of point-of-care lateral flow rapid diagnostic tests for veterinary use, serving veterinarians and livestock farmers across the DACH region with a portfolio of more than 50 consumable test kits for companion animals, livestock, and equine applications.

What Fassisi GmbH does

Fassisi GmbH, founded in 2010 and headquartered in the Göttinger Biotechnologiepark (Marie-Curie-Strasse 8, 37079 Göttingen, Germany), is a specialized German manufacturer and developer of point-of-care lateral flow immunoassay (rapid test) systems for veterinary diagnostics. The company produces a portfolio of more than 50 individual rapid test kits covering companion animals (dogs and cats — including Parvo, Corona, FIV, FeLV, Giardia, Leishmania, Lyme, distemper, and vaccination titer tests), large animals (cattle, calves, pigs, lambs, horses, foals — including BoDia variants, BoviPreg for bovine pregnancy, Bovine IgG for passive immunity, PiDia, TetaCheck), and environmental/other applications (BoTick for Borrelia detection in ticks, AllerBovine for bovine allergen detection). The technology platform is built on three proprietary differentiators: the Fassisi-tag (enhanced test performance tag used in products such as FeLFIV), Blue Latex Detection Technology (used in Giardia tests for clearer visual reading), and a Multiplex platform enabling simultaneous detection of multiple pathogens in a single test.

The company operates under audited international quality standards including ISO 9001:2015, GMP certification, and holds manufacturer permits under both §13 AMG (Arzneimittelgesetz) and TierSG (Tierseuchengesetz), a combination that is rare among veterinary rapid test providers. Manufacturing takes place at the Göttingen facility, which was expanded in December 2020 with relocation to larger premises within the Science Park III biotechnology cluster.

Fassisi's revenue model is built on two streams: (1) one-time sales of branded rapid diagnostic test kits through veterinary wholesalers and distribution partners (Vertriebspartner) across Germany, Austria, and Switzerland, supplemented by direct sales via the Fassisi online shop with free domestic shipping above €40; and (2) a smaller professional services stream offering contract development and manufacturing (Auftragsentwicklung) for animal health companies and research institutions requiring custom test development leveraging Fassisi's platform technologies. The company maintains a wholly-owned Austrian subsidiary, Fassisi AT GmbH (established 2017), which distributes specific product lines (T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, CantiCheck Plus) into Austria. GTM is multi-channel: B2B sales-led targeting veterinarians in small and large animal practice, channel partner distribution, and event-driven demand generation with active participation in major veterinary congresses (Leipziger Tierärztekongress, DeutscheVET, bpt-Kongress). The company is privately held with no institutional investor or public market involvement disclosed.

Fassisi GmbH firmographics

Firmographics
Name
Fassisi GmbH
Legal name
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH
Website
https://fassisi.de
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
Fassisi GmbH is a Göttingen, Germany-based manufacturer of point-of-care lateral flow rapid diagnostic tests for veterinary use, serving veterinarians and livestock farmers across the DACH region with a portfolio of more than 50 consumable test kits for companion animals, livestock, and equine applications.
Ownership category
akta.pro rank

Fassisi GmbH industry classification

Industry
Product category
Veterinary Diagnostics
NAICS
Veterinary Services (54194), Support Activities for Animal Production (1152)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAHAOAL
Veterinary POCT & Rapid Diagnostics (Animal health rapid tests)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMADAD
Veterinary Parasitology Testing
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYAFACADAF
Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation)
SECONDARYHLAMAEAG
Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Veterinary diagnostic tests
  • Rapid immunoassay tests
  • Lateral flow assays
  • Animal health diagnostics
  • Point-of-care testing

Where Fassisi GmbH is headquartered

Location

Headquarters

HQ city
Göttingen
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Fassisi GmbH business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Veterinary Rapid Test Products: One-time sale of rapid diagnostic test kits for veterinary use. Products are sold to veterinarians (Tierärzte) and livestock farmers through veterinary wholesalers, distribution partners, and directly via the Fassisi online shop. The product range covers point-of-care tests for small animals (cats, dogs) and large animals (cattle, calves, pigs, lambs, horses, foals).
  2. Contract Development Services: Custom test development and manufacturing services (Auftragsentwicklung) for customer-specific parameters. Fassisi offers full in-house development and production, leveraging their platform technologies and experience with various species and sample materials. This represents a professional services / project-based revenue stream.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProducts available via online shop and distribution partners

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Fassisi GmbH product offering

Product offering

Core offering

Fassisi GmbH develops, manufactures, and distributes veterinary in-vitro rapid diagnostic test kits (lateral flow immunoassays) for point-of-care use by veterinarians and livestock producers. The portfolio spans companion-animal pathogen tests (e.g., Parvo, Corona, Giardia, FeLV/FIV, Leishmania, Ehrlichia), canine vector-borne disease panels, and livestock tests for reproductive status, metabolic disorders, passive transfer, and allergen exposure (e.g., BoviPreg, PiDia, Bovine IgG, TetaCheck, AllerBovine). The company also offers contract development and OEM manufacturing services for external animal-health clients.

Product overview

Fassisi GmbH is a German manufacturer and developer of veterinary diagnostic rapid test systems based in Göttingen, Germany. The product portfolio consists of rapid test systems organized into three main categories: products for large animals (cattle, calves, pigs, lambs, horses, and foals), products for small animals (dogs and cats), and environmental/other products. The core technology platform includes the Fassisi Multiplex system enabling multiplex detection. For large animals, key products include BoDia (and its variants: MPX, Advance MPX, Plus, +Gia) for diarrhea pathogens, BoviPreg for bovine pregnancy detection, Bovine IgG for passive immunity assessment, PiDia/PiDia Light for young animal pathogens, and TetaCheck for equine tetanus antibody titers. For small animals, the portfolio includes pathogen-specific tests (Parvo, Corona, FIV, FeLV, GiarDia, LymeBo, EhrCanis, LeishMa, CanDis, CanDiro), combination tests (ParCo, Triple, FeLFIV), and advanced multiplex products (CanVecto 3, CanVecto 4, CantiCheck Plus). The BoTick detects Borrelia in ticks, and AllerBovine detects bovine allergens in dust. The company also offers contract development services for custom diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

  • Fassisi-tag: Proprietary technology used in Fassisi rapid tests for enhanced test performance and accuracy.

Products and services

  • Fassisi Multiplex test platform Proprietary platform combining multiple veterinary pathogen detections in a single lateral flow test, used as the technological basis for the BoDia, Giardia+CPE, and Triple family products.
  • BoDia (canine Giardia + blood-detection add-on) Rapid in-clinic test for detection of Giardia antigen in dogs, with MPX/Advance MPX/Plus variants adding additional combined antigen detection for the same sample.
  • ParCo (Parvovirus + Coronavirus double test) Rapid in-clinic test that simultaneously detects canine Parvovirus and Coronavirus antigens in fecal samples for differential diagnosis of acute diarrhea in dogs.
  • Parvo (canine Parvovirus single test) Rapid in-clinic antigen test for canine Parvovirus in fecal samples, used for confirming parvoviral enteritis in dogs.
  • Corona (canine Coronavirus single test) Rapid in-clinic antigen test for canine Coronavirus in fecal samples.
  • GiarDia (canine Giardia single test) Rapid in-clinic antigen test for Giardia in canine fecal samples, with a later latex-enhanced version (GiarDia Latex) launched in March 2013.
  • Giardia+CPE / Giardia+CPE MPX Multiplex rapid test for combined detection of Giardia and Clostridium perfringens enterotoxin (CPE) in canine fecal samples.
  • CryGiDia / CryGiDia MPX Rapid antigen test detecting Cryptosporidium and Giardia simultaneously in canine fecal samples.
  • Triple / Triple MPX Multiplex rapid test combining detection of three companion-animal pathogens (e.g., Parvo/Corona/Giardia) in a single test cassette.
  • ThyroControl Cat / T4 Rapid in-clinic semi-quantitative test for total thyroxine (T4) in cats, used for screening and monitoring hyperthyroidism.
  • FeLV (Feline Leukemia Virus test) Rapid in-clinic antigen test for Feline Leukemia Virus (FeLV p27 antigen) in cat blood samples.
  • FIV (Feline Immunodeficiency Virus test) Rapid in-clinic antibody test for Feline Immunodeficiency Virus (FIV) in cat blood samples.
  • FeLFIV (combined FeLV + FIV test with Fassisi-tag) Combined rapid test detecting both FeLV antigen and FIV antibody in cat blood samples using Fassisi-tag blue-latex detection technology.
  • Feline Triple (Feline ParvoCheck + FeLV + FIV) Rapid in-clinic test combining feline panleukopenia (parvovirus) antigen detection with FeLV and FIV screening in cats.
  • Feline ParvoCheck Rapid in-clinic antigen test for feline panleukopenia (feline parvovirus) in fecal samples.
  • CanDis (canine Distemper test) Rapid in-clinic antigen test for canine Distemper virus (CDV) in ocular or nasal secretions.
  • CanDiro (canine Dirofilaria test) Rapid in-clinic antigen test for Dirofilaria immitis (canine heartworm) in dog blood samples.
  • LeishMa (canine Leishmaniasis test) Rapid in-clinic test for Leishmania infantum antibodies/antigens in dog blood samples.
  • LymeBo (Lyme Borreliosis test) Rapid in-clinic antibody test for Borrelia burgdorferi (Lyme disease) in dog blood samples.
  • EhrCanis (Ehrlichia canis test) Rapid in-clinic antibody test for Ehrlichia canis in dog blood samples.
  • EhrLeish (Ehrlichia + Leishmania test) Rapid in-clinic antibody test for combined detection of Ehrlichia and Leishmania exposure in dogs.
  • CanVecto Trio Rapid in-clinic antibody panel for combined detection of canine vector-borne pathogens (e.g., Ehrlichia/Anaplasma/Borrelia/Leishmania group) in dog blood samples.
  • CanVecto 3 Rapid in-clinic three-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.
  • CanVecto 4 Rapid in-clinic four-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.
  • CantiCheck Plus / CantiCheck MPX Multiplex rapid test combining multiple antigen/antibody detections relevant to canine infectious disease screening in a single cassette.
  • BoviPreg (bovine pregnancy test) Rapid on-farm pregnancy test for cattle, detecting pregnancy-associated glycoproteins in serum or plasma.
  • Bovine IgG Rapid test for measurement of bovine IgG in serum or plasma to assess failure of passive transfer in neonatal calves.
  • PiDia Rapid in-clinic test for fructosamine (glycated protein) in dog and cat serum, used for monitoring long-term glycemic control in diabetic patients.
  • PiDia Light Streamlined version of the PiDia fructosamine test for diabetic monitoring in dogs and cats, with reduced workflow for routine practice use.
  • TetaCheck (bovine ketone / metabolic test) Rapid on-farm test for detection of ketone bodies (β-hydroxybutyrate) in bovine milk or blood, used for subclinical ketosis screening in dairy cows.
  • Equine IgG Rapid test for measurement of equine IgG in foal serum to assess failure of passive transfer in neonatal foals.
  • AllerBovine (bovine allergen exposure test) Rapid test for detection of allergen-specific IgE antibodies in cattle, used to assess allergen exposure relevant to bovine allergic disease.
  • BoTick (Babesia / Babesia spielmanii tick test) Rapid test for detection of Babesia antibodies (including B. spielmanii) in dog blood samples; revised version released July 2013.
  • Contract Development Services Service offering under which Fassisi develops and OEM-manufactures custom lateral flow immunoassay veterinary diagnostic tests for external animal-health companies, leveraging the Fassisi-tag platform and GMP/§13 AMG-certified facility.

Quantifiable outcome

  • CantiCheck Plus achieved 98.11% sensitivity and 99.99% specificity for CPV antibodies in an independent study (Viruses 2021), outperforming three other commercially available point-of-care tests.
  • +1 more outcomes

Companies that use Fassisi GmbH

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Fassisi GmbH technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Fassisi GmbH partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Fassisi AT GmbHcoreOthers · 7 April 2017Fassisi AT GmbH is a subsidiary of Fassisi GmbH based in Austria. It distributes specific Fassisi products in the Austrian market and serves as the Austrian sales and distribution entity. Products distributed include Fassisi T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, and CantiCheck Plus.
  • Veterinary Distributors / Wholesalers (Vertriebspartner)coreChannel Partner/ Reseller/ DistributorFassisi sells all products through veterinary distribution partners (Vertriebspartner). These partners distribute Fassisi rapid tests across Germany, Austria, Switzerland, and other German-speaking markets. Distribution partners are the primary route to market for reaching veterinarians and livestock farmers.
  • Scientific Partner NetworkminorStrategic or Co-development PartnerFassisi maintains a network of scientific partners for handling complex diagnostic questions in custom development projects. This network supports the company's Auftragsentwicklung (contract development) services, enabling development of tests for complex parameters and applications.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Fassisi GmbH competitors and assessment

Company assessment

Broad incumbents

  • Virbac: Global animal health company with a diagnostics portfolio including rapid tests for companion animals and livestock. Virbac's broader pharmaceutical and vaccine offering makes it a broad incumbent that overlaps with Fassisi's on-farm and clinic-based rapid testing.
  • Heska (Mars Petcare): Now part of Mars Petcare, Heska sells point-of-care veterinary diagnostics including in-clinic analyzers and rapid test kits for companion animals. The company competes most directly with Fassisi's small animal lateral flow portfolio while also operating broader diagnostic platforms.
  • IDEXX Laboratories: Global leader in veterinary diagnostics with reference lab services and in-clinic analyzers (Catalyst Dx, ProCyte Dx, SNAP rapid tests). Comparable because SNAP rapid tests directly compete with Fassisi's lateral flow portfolio in companion animal practice, though IDEXX operates at much greater scale and across a broader diagnostics portfolio.
  • Zoetis: Largest global animal health company offering diagnostics, vaccines, and pharmaceuticals. Zoetis's Vetscan rapid test suite and reference lab services overlap with Fassisi's companion animal and livestock offerings, though Zoetis competes across a much broader portfolio and at significantly greater scale.

Emerging players

  • Alvedia: French veterinary diagnostics company specializing in rapid blood typing tests for companion animals. Comparable to Fassisi as a focused European veterinary rapid test manufacturer, though Alvedia operates in a narrower niche (blood typing) than Fassisi's broader infectious disease portfolio.

Direct peers

  • Eurolyser Diagnostica: Austrian manufacturer of point-of-care veterinary diagnostic tests and analyzers with a focus on small animal and livestock practice. Closely comparable to Fassisi on technology (lateral flow POC), geographic focus (DACH/Austria), and customer base (veterinary practices and laboratories).
  • INDICAL BIOSCIENCE: Germany-based developer and manufacturer of veterinary diagnostics, including rapid tests and PCR kits for companion animals and livestock. Highly comparable to Fassisi as a German-headquartered veterinary diagnostics manufacturer serving similar European markets with overlapping product categories.
  • Innovative Diagnostics (IDvet): French veterinary diagnostics manufacturer specializing in ELISA kits and rapid tests for livestock and companion animals. Comparable to Fassisi as a focused veterinary diagnostics manufacturer with B2B distribution to veterinary practices and labs, though IDvet is larger and more export-oriented.
  • Scil Animal Care: German-based veterinary diagnostics company offering in-clinic analyzers and rapid tests for companion animals and livestock. Direct peer to Fassisi given similar German-speaking market focus, B2B distribution model, and rapid test product portfolio.
  • MEGA COR Diagnostik: Austrian veterinary diagnostics company selling the FASTest brand of rapid in-clinic tests for companion animals and livestock. Direct peer to Fassisi given overlapping product portfolio (lateral flow POC), regional focus (DACH), and veterinary customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Fassisi GmbH social profiles

Digital presence

Fassisi GmbH compliance and trust

Trust signal

Compliance6 records

Fassisi GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fassisi GmbH leadership team

Management profile

Number of profiles

Profiles2 records

Fassisi GmbH subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Fassisi GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fassisi GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fassisi GmbH

What does Fassisi GmbH do?

Fassisi GmbH develops, manufactures, and distributes veterinary in-vitro rapid diagnostic test kits (lateral flow immunoassays) for point-of-care use by veterinarians and livestock producers. The portfolio spans companion-animal pathogen tests (e.g., Parvo, Corona, Giardia, FeLV/FIV, Leishmania, Ehrlichia), canine vector-borne disease panels, and livestock tests for reproductive status, metabolic disorders, passive transfer, and allergen exposure (e.g., BoviPreg, PiDia, Bovine IgG, TetaCheck, AllerBovine). The company also offers contract development and OEM manufacturing services for external animal-health clients.

Is Fassisi GmbH a public or private company?

Fassisi GmbH is a private company. It is classified as management employee owned and is currently operating.

When was Fassisi GmbH founded?

Fassisi GmbH was founded in 2010. It employs 1 to 10 people.

Where is Fassisi GmbH based?

Fassisi GmbH is headquartered in Göttingen, Germany, in the Europe region.

How does Fassisi GmbH make money?

Two revenue lines are on record. Veterinary Rapid Test Products are the primary driver. The others are contract Development Services.

Who are Fassisi GmbH's main competitors?

Broad incumbents on record are Virbac, Heska (Mars Petcare), IDEXX Laboratories and Zoetis. Alvedia is listed as an emerging player. Direct peers are Eurolyser Diagnostica, INDICAL BIOSCIENCE, Innovative Diagnostics (IDvet), Scil Animal Care and MEGA COR Diagnostik.

Does Fassisi GmbH have an API?

No public API is recorded for Fassisi GmbH.

What industry is Fassisi GmbH in?

Fassisi GmbH's product category is Veterinary Diagnostics. Its primary akta.pro industry code is HLAHAOAL, Veterinary POCT & Rapid Diagnostics (Animal health rapid tests), with a secondary code of HLAMADAC, Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology). Its NAICS code is 54194 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales